20
Participants
Start Date
December 31, 2011
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2019
intralesional rituximab
10-20 mg (1-2 ml) rituximab once a week for 4 weeks; followed by 10-20 mg (1-2 ml) rituximab monthly per six months
supplemental autologous serum
patients in PD or SD during or after administration of 6 doses monthly rituximab will be administered the same dose of intralesional rituximab supplemented by autologous serum
Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor, Milan
Andres J. M. Ferreri
OTHER